OUR NEWS & EVENTS

Dec 12, 2022

EpiEndo Pharmaceuticals to attend SCIENCE4PEACE

SCIENCE4PEACE is a unique manifestation of the Swedish - American Life Science Summit (SALSS) together with The Galien Foundation, taking...

Nov 14, 2022

Commencement of Ph2a trial for EP395 in COPD patients

EpiEndo commences Phase 2a trial for EP395 in COPD patients Regulatory approval for first patient study of first non-antibiotic macrolide...

Aug 31, 2022

Commencement of LPS challenge trial for lead candidate EP395

Regulatory approval for proof of pharmacology study for the first non-antibiotic macrolide REYKJAVIK, ICELAND – 31 August 2022 – EpiEndo...

Jun 15, 2022

Dag Nesse appointed as Director of Clinical Operations

REYKJAVIK, ICELAND – 15 June 2022 – EpiEndo Pharmaceuticals (‘EpiEndo’ or the ‘Company’), the clinical-stage biopharmaceutical company...

May 18, 2022

Successful completion of Phase I Study for lead asset EP395

· First non-antibiotic macrolide to go into clinical development – targeting COPD · Safety, tolerability and pharmacokinetic...

May 9, 2022

Dr Isaac Cohen and Dr Eugen Steiner appointed to EpiEndo’s Board of Directors

REYKJAVIK, ICELAND – 9 May 2022 – EpiEndo Pharmaceuticals (‘EpiEndo’ or the ‘Company’), the clinical-stage biopharmaceutical company...

Apr 21, 2022

EpiEndo expands operations with new facility in Sweden’s largest life science cluster

Grows team across Sweden, Denmark, Iceland, and the UK REYKJAVIK, ICELAND – 21 April 2022 – EpiEndo Pharmaceuticals (‘EpiEndo’), the...

Mar 24, 2022

EpiEndo Pharmaceuticals expands its leadership team, appointing Stefan Petursson as CFO

REYKJAVIK, ICELAND – 24 March 2022 – EpiEndo Pharmaceuticals is pleased to announce the appointment of Stefan Petursson as Chief...

Feb 14, 2022

EpiEndo - A Nordic star on a Global mission!

In the January edition of the Nordic Life Science Magazine (www.nordiclifescience.org), the leading life science business magazine in the...

Jan 10, 2022

We are looking for a biology technician at EpiEndo Pharmaceuticals, is that you?

EpiEndo Pharmaceuticals is an Icelandic clinical stage pharmaceutical company with a unique focus on impairment of epithelial barriers as...

Jan 10, 2022

We are looking for a biologist at EpiEndo Pharmaceuticals, is that you?

EpiEndo Pharmaceuticals is a clinical stage pharmaceutical company with a unique focus on impairment of epithelial barriers as a common...

Dec 13, 2021

We are looking for a Director Clinical Operations at EpiEndo Pharmaceuticals, is that you?

EpiEndo is a clinical stage pharmaceutical company with a unique focus on impairment of epithelial barriers as a common mechanism of many...

Oct 25, 2021

EpiEndo Pharma wins the Swedish American Life Science Summit (SALSS) Rising Star Award 2021

EpiEndo Pharma receives the Swedish American Life Sciences Summit (SALSS) Rising Star Award 2021 for its innovation and potential impact in

Aug 18, 2021

EpiEndo Secures €20 Million Series A Funding

EpiEndo Pharmaceuticals Secures €20M Series A Funding to Advance Clinical Development of its Lead Compound EP395 for the Treatment of COPD

Jun 2, 2021

EpiEndo Wins #1 Place in Biotech & Pharmaceuticals, at the European Innovation Council Investor Day

EpiEndo is announced as the winner of the Biotech & Pharmaceuticals category, at the European Innovation Council Investor Day on Health 2021

Apr 15, 2021

EpiEndo Announces €2.7 million Investment by the European Innovation Council (EIC) Fund

EpiEndo Pharma is the recipient of a €2.7 million convertible loan from the European Innovation Council (EIC) Fund.

Apr 13, 2021

EpiEndo Pharmaceuticals Announces Launch of First-in-Human Clinical Trial of Lead Candidate EP395

First-in-Human Clinical Trial of EpiEndo’s Lead Compound, EP395, for Chronic Inflammatory Airway Diseases Commences at the Medicines...

Apr 6, 2021

EpiEndo Pharma announces the Appointment of Sigriður Valgeirsdóttir and Robert Helgason

EpiEndo Pharmaceuticals is pleased to announce the appointment of Dr. Sigríður Valgeirsdóttir and Robert Helgason to the Company’s Board

Mar 5, 2021

EpiEndo and AlveoliX Receive Eurostar Grant

EpiEndo Pharmaceuticals is pleased to announce that their consortium project EPIcoliX has been officially recognized as a Eurostar...

Mar 2, 2021

EpiEndo Pharma Builds Science and Medical Leadership with Appointment of New CSO & CMO